Quick Answer
Adagio Medical Holdings, Inc. reported Total Revenue of $0.00 for fiscal year 2025.
Adagio Medical Holdings, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Revenue | $0.00 | — | $300.0K | — |
| Revenue (ASC 606) | $0.00 | — | $300.0K | — |
| Net Income | -$25.08M | — | -$36.59M | — |
| Diluted EPS | -$1.51 | — | -$48.16 | — |
| Total Assets | $43.25M -10.7% |
$48.45M +609.9% |
$6.83M | — |
| Cash and Equivalents | $17.11M -16.9% |
$20.59M +1388.5% |
$1.38M | — |
| Stockholders Equity | $12.40M -83.0% |
$72.96M +155.3% |
-$132.02M -37.7% |
-$95.88M |
| R&D Expense | $10.64M | — | $15.40M | — |
| Operating Income | -$21.89M | — | -$27.94M | — |
| Shares Outstanding | 22.21M +2747.8% |
779,908 +0.0% |
779,908 | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $0.00 | -100.0% | -100.0% |
| Revenue (ASC 606) | September 30, 2025 | $0.00 | -100.0% | -100.0% |
| Net Income | September 30, 2025 | -$10.12M | -380.6% | -156.3% |
| Diluted EPS | September 30, 2025 | -$0.66 | -3400.0% | -88.6% |
| Total Assets | September 30, 2025 | $31.55M | -70.6% | -12.1% |
| Cash and Equivalents | September 30, 2025 | $4.67M | -83.5% | -43.0% |
| Stockholders Equity | September 30, 2025 | -$1.31M | -101.7% | -115.1% |
| R&D Expense | September 30, 2025 | $2.77M | +127.9% | +40.7% |
| Operating Income | September 30, 2025 | -$5.72M | -29.3% | -21.3% |
| Shares Outstanding | September 30, 2025 | 15.38M | +5.8% | +0.0% |
- Adagio Medical Holdings, Inc. reported Total Revenue of $0.00 for fiscal year 2025.
- Adagio Medical Holdings, Inc. showed a decrease of -100.0% in Total Revenue compared to the prior fiscal year.
- Adagio Medical Holdings, Inc. reported Revenue (ASC 606) of $0.00 for fiscal year 2025.
- Adagio Medical Holdings, Inc. showed a decrease of -100.0% in Revenue (ASC 606) compared to the prior fiscal year.
- Adagio Medical Holdings, Inc. reported Net Income of -$25.08 million for fiscal year 2025.
- Adagio Medical Holdings, Inc. showed an increase of +31.4% in Net Income compared to the prior fiscal year.
- Adagio Medical Holdings, Inc. reported Diluted EPS of $1.51 per share (loss) for fiscal year 2025.
- Adagio Medical Holdings, Inc. showed an increase of +96.9% in Diluted EPS compared to the prior fiscal year.
- Adagio Medical Holdings, Inc. reported Total Assets of $43.25 million for fiscal year 2025.
- Adagio Medical Holdings, Inc. showed a decrease of -10.7% in Total Assets compared to the prior fiscal year.
- Adagio Medical Holdings, Inc. reported Cash and Equivalents of $17.11 million for fiscal year 2025.
- Adagio Medical Holdings, Inc. showed a decrease of -16.9% in Cash and Equivalents compared to the prior fiscal year.
- Adagio Medical Holdings, Inc. reported Stockholders Equity of $12.40 million for fiscal year 2025.
- Adagio Medical Holdings, Inc. showed a decrease of -37.7% in Stockholders Equity compared to the prior fiscal year.
- Adagio Medical Holdings, Inc. reported R&D Expense of $10.64 million for fiscal year 2025.
- Adagio Medical Holdings, Inc. showed a decrease of -30.9% in R&D Expense compared to the prior fiscal year.
- Adagio Medical Holdings, Inc. reported Operating Income of -$21.89 million for fiscal year 2025.
- Adagio Medical Holdings, Inc. showed an increase of +21.7% in Operating Income compared to the prior fiscal year.
- Adagio Medical Holdings, Inc. reported Shares Outstanding of 22.21 million shares for fiscal year 2025.
- Adagio Medical Holdings, Inc. showed an increase of +46.1% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: